Quick Takeaways
- Michael Geffner has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $4,147,740.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Michael Geffner
- Location
- New York, NY
- Summary
- The estimated net worth of Michael Geffner is at least $4,147,740 dollars as of 24 Oct 2025. Michael Geffner is the Chief Medical Officer of Immunovant, Inc. and owns shares of Immunovant, Inc. (IMVT) stock worth about $4.15M.
- Signature
- /s/ Tiago Girao, attorney-in-fact for Michael Geffner
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Michael Geffner and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Immunovant, Inc. ($4,147,740).
- Past-year value change for that position: -$168,144.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Michael Geffner
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | Chief Medical Officer | $4,147,740 | -$168,144 | -3.9% | 22 Oct 2025 |
Insider Transactions Reported by Michael Geffner:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.